Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
70.8 CHF | -0.28% | -1.94% | +39.10% |
Apr. 26 | Cosmo Pharmaceuticals N.V. Announces Executive Changes at the Upcoming Annual General Meeting on 24 May 2024 | CI |
Apr. 25 | Cosmo Pharmaceuticals Names New CEO, Chairman | MT |
Sales 2023 | 96.72M 104M 94.4M | Sales 2024 * | 262M 282M 256M | Capitalization | 1.16B 1.25B 1.14B |
---|---|---|---|---|---|
Net income 2023 | 1M 1.08M 976K | Net income 2024 * | 111M 120M 108M | EV / Sales 2023 | 8.6 x |
Net cash position 2023 | 48.44M 52.16M 47.27M | Net cash position 2024 * | 110M 119M 108M | EV / Sales 2024 * | 4.02 x |
P/E ratio 2023 |
771
x | P/E ratio 2024 * |
9.96
x | Employees | 319 |
Yield 2023 |
3.65% | Yield 2024 * |
2.9% | Free-Float | 44.49% |
Latest transcript on Cosmo Pharmaceuticals N.V.
1 day | -0.28% | ||
1 week | -1.94% | ||
Current month | -2.07% | ||
1 month | +0.71% | ||
3 months | +10.62% | ||
6 months | +93.44% | ||
Current year | +39.10% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 61 | 05-12-31 | |
Niall Donnelly
DFI | Director of Finance/CFO | 52 | 16-05-31 |
Chief Tech/Sci/R&D Officer | 54 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
David W Maris
BRD | Director/Board Member | 57 | 21-05-27 |
Founder | 69 | 96-12-31 | |
Director/Board Member | 64 | 05-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 10 M€ | -3.35% | - | |
0.00% | 0 M€ | -.--% | - | |
0.00% | 0 M€ | +3.63% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 70.8 | -0.28% | 14,691 |
24-05-08 | 71 | -1.25% | 8,539 |
24-05-07 | 71.9 | -0.83% | 13,332 |
24-05-06 | 72.5 | +0.42% | 14,718 |
24-05-03 | 72.2 | +0.84% | 11,784 |
Delayed Quote Swiss Exchange, May 10, 2024 at 11:31 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+39.10% | 1.25B | |
+30.38% | 684B | |
+26.51% | 568B | |
-4.36% | 361B | |
+19.30% | 329B | |
+3.73% | 284B | |
+16.70% | 240B | |
+8.78% | 208B | |
-7.93% | 200B | |
+7.68% | 166B |
- Stock Market
- Equities
- COPN Stock